Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS2330 in Parkinson's Disease
NCT00006077Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Aug 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tesofensine in Parkinson's disease (PD), sponsored by National Institute of Neurological Disorders and Stroke. Started Aug 2000; status: completed.
02
Drugs
tesofensine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00006077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006077.